These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33149882)

  • 1. Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications.
    Bullón-Vela V; Abete I; Tur JA; Konieczna J; Romaguera D; Pintó X; Corbella E; Martínez-González MA; Sayón-Orea C; Toledo E; Corella D; Macías-Gonzalez M; Tinahones FJ; Fitó M; Estruch R; Ros E; Salas-Salvadó J; Daimiel L; Mascaró CM; Zulet MA; Martínez JA
    Ther Adv Endocrinol Metab; 2020; 11():2042018820958298. PubMed ID: 33149882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome.
    Kuo TC; Lu YB; Yang CL; Wang B; Chen LX; Su CP
    BMC Gastroenterol; 2024 Jan; 24(1):26. PubMed ID: 38195414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Six Insulin Resistance Surrogates and Nonalcoholic Fatty Liver Disease Among Older Adults: A Cross-Sectional Study.
    Li H; Shi Z; Chen X; Wang J; Ding J; Geng S; Sheng X; Shi S
    Diabetes Metab Syndr Obes; 2023; 16():1685-1696. PubMed ID: 37309507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
    Zeng P; Cai X; Yu X; Gong L
    Sci Rep; 2023 Nov; 13(1):20470. PubMed ID: 37993481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults.
    Lee SB; Kim MK; Kang S; Park K; Kim JH; Baik SJ; Nam JS; Ahn CW; Park JS
    Endocrinol Metab (Seoul); 2019 Jun; 34(2):179-186. PubMed ID: 31257745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Metabolic Score for Insulin Resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic Fatty Liver Disease in Hyperuricemia Subjects.
    Shu Y; Huang G; Mao Y
    Diabetes Metab Syndr Obes; 2023; 16():4235-4246. PubMed ID: 38169634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease.
    Zhang Y; Wang R; Fu X; Song H
    Diabetol Metab Syndr; 2022 Dec; 14(1):191. PubMed ID: 36528713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults.
    Taheri E; Pourhoseingholi MA; Moslem A; Hassani AH; Mousavi Jarrahi A; Asadzadeh Aghdaei H; Zali MR; Hatami B
    J Diabetes Metab Disord; 2022 Jun; 21(1):97-107. PubMed ID: 35673435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation.
    Li X; Zhan F; Peng T; Xia Z; Li J
    Eur J Med Res; 2023 Sep; 28(1):355. PubMed ID: 37726807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease.
    Kim B; Jin HY; Yoon JS; Noh ES; Hwang IT
    J Clin Res Pediatr Endocrinol; 2024 Apr; ():. PubMed ID: 38664989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease.
    Naseri K; Saadati S; Yari Z; Askari B; Mafi D; Hoseinian P; Asbaghi O; Hekmatdoost A; de Courten B
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
    Xue Y; Xu J; Li M; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
    Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
    Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
    [No Abstract]   [Full Text] [Related]  

  • 17. High triglyceride-glucose index and HOMA-IR are associated with different cardiometabolic profile in adults from the ELSA-Brasil study.
    Lelis DF; Baldo TOF; Andrade JMO; Griep RH; Bensenor I; Lotufo PA; Mill JG; Baldo MP
    Clin Biochem; 2024 Jul; 131-132():110793. PubMed ID: 38996957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Lee JH; Kwon YJ; Park K; Lee HS; Park HK; Han JH; Ahn SB
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome.
    Son DH; Lee HS; Lee YJ; Lee JH; Han JH
    Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):596-604. PubMed ID: 35090800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.